Knoglemarvskræft - langtidsoverlevelse vokser voldsomt
-
Langtidsoverlevelse vokser voldsomt for patienter med knoglemarvskræft
Skrevet af Ebbe Fischer d. 4. juni 2021 i kategorien Nyheder
Ifølge Dansk Myelomatose Databases seneste årsrapport medfører nye effektive behandlinger, at langt flere patienter med knoglemarvskræft (myelomatose) overlever i lang tid. Ifølge professor Torben Plesner er den reelle effekt endda væsentlig større, end tallene viser.Læs mere:
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind